Profile: Medtronic, Inc. specializes in medical technology, thus providing lifelong solutions for people with chronic pain. We focus on cardiac rhythm disease management (CRDM), spinal & biologics, cardiovascular, neuromodulation, diabetes, and surgical technologies. Our cardiac resynchronization therapy (CRT) devices for heart failure include Consulta™ CRT defibrillator, Maximo™ CRT defibrillator, Concerto™ CRT defibrillator, Insync Maximo™ CRT defibrillator and Carelink remote monitoring network. CRDM's primary product lines are implantable pacemakers, implantable cardioverter-defibrillators (ICDs), implantable cardiac resynchronization therapy devices and monitoring systems. Our latest ICDs include a feature called OptiVol fluid monitoring, which allows physicians to continually track their patients fluid status using intrathoracic impedance (changes in the fluid flow). It provides trending data so that physicians can adjust medical treatment for patients at risk of acute decompensated heart failure. We also provide a unique, insertable diagnostic monitor for implantable pacemakers that can help physicians determine if unexplained fainting may be the result of an abnormally slow heart rhythm.

The company was founded in 1976, has revenues of USD 1-5 Million, has ~50 employees and is CE certified.

FDA Registration Number: 1721332